A rare disease drug is rejected, even as the FDA talks about new approval pathway The FDA decision is ‘confusing’ and ‘shocking,’ said Stealth CEO Reenie McCarthy

https://www.statnews.com/pharmalot/2025/05/29/fda-biotech-pharma-medicines-stealth-approval-accelerated-barth-rare-disease/